Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Masahiro Tajika"'
Autor:
Kensuke Kubota, Yasuhiro Shimizu, Masahiro Obata, Nozomi Okuno, Masahiro Tajika, Yusuke Kurita, Yasumasa Niwa, Hiroki Koda, Takamichi Kuwahara, Shimpei Matsumoto, Kazuo Hara, Nobumasa Mizuno, Atsushi Nakajima
Publikováno v:
Digestive Endoscopy. 32:399-408
Background and aim In chronic pancreatitis (CP) patients, diagnosis of small pancreatic lesions by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is challenging. Thus, the aim of the present study was to investigate whether CP influenc
Autor:
Tsutomu Tanaka, Sachiyo Oonishi, Kei Muro, Toshiki Masuishi, Tetsuya Abe, Takeshi Kodaira, Seiichiro Mitani, Yutaka Hirayama, Masahiro Tajika, Yutaro Koide, Yukiya Narita, Shigenori Kadowaki, Hideaki Bando, Isao Oze
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 1, Pp 394-400 (2020)
Cancer Medicine, Vol 9, Iss 1, Pp 394-400 (2020)
Background Esophageal cancer is associated with synchronous or metachronous cancer at other primary sites. However, few studies have evaluated the second malignancies after the treatment of esophageal cancer. The present study aimed to clarify the fr
Autor:
Yasuhiro Shimizu, Tomoyasu Kamiya, Keisaku Yamada, Sachiyo Onishi, Yasumasa Niwa, Masahiro Tajika, Tsutomu Tanaka, Seiji Natsume
Publikováno v:
Internal medicine (Tokyo, Japan). 61(10)
Primary hepatocellular carcinoma (HCC) in patients
Autor:
Toshiki Masuishi, Takatsugu Ogata, Kazuo Hara, Taiko Nakazawa, Kei Muro, Yuki Matsubara, Kazuki Nozawa, Kazunori Honda, Yukiya Narita, Kyoko Kato, Hideaki Bando, Masahiro Tajika, Masashi Ando, Shigenori Kadowaki, Ryosuke Kumanishi
Publikováno v:
Anticancer research. 41(10)
Background/aim Metastatic small bowel adenocarcinoma (SBA) is a rare disease with poor prognosis. This study aimed to explore the efficacy and safety of second-line chemotherapy for patients with SBA. Patients and methods We retrospectively reviewed
Autor:
Hideaki Bando, Takatsugu Ogata, Yukiya Narita, Shigenori Kadowaki, Masashi Ando, Taiko Nakazawa, Masahiro Tajika, Kazuki Nozawa, Ryosuke Kumanishi, Kei Muro, Toshiki Masuishi, Kazunori Honda, Yuki Matsubara, Kyoko Kato
Publikováno v:
American journal of clinical oncology. 44(8)
OBJECTIVES Insufficient oral intake in advanced gastric cancer (AGC) limits the use of several drugs. We aimed to determine the oral intake status of patients with AGC during later-line chemotherapy. MATERIALS AND METHODS We retrospectively evaluated
Autor:
Yasumasa Niwa, Mariko Naito, Takahisa Kawaguchi, Hidemi Ito, Michael C. Wu, Yoshiyuki Watanabe, Masahiro Tajika, Yukihide Momozawa, Keitaro Matsuo, Michiaki Kubo, Takeshi Nishiyama, Fumihiko Matsuda, Teruhide Koyama, Daisuke Matsui, Isao Oze, Sadao Suzuki, Hiroko Nakagawa-Senda, Masahiro Nakatochi, Ryosuke Fujii, Asahi Hishida, Kenji Wakai, Tomotaka Ugai
Publikováno v:
Carcinogenesis. 40:661-668
Although recent genome-wide association studies (GWASs) have identified genetic variants associated with Helicobacter pylori (HP)-induced gastric cancer, few studies have examined the genetic traits associated with the risk of HP-induced gastric prec
Autor:
Hitoshi Ando, Hiroya Taniguchi, Shoji Fukushima, Masaki Kajita, Masahiro Aoki, Shigenori Kadowaki, Ayako Hasegawa, Akimitsu Maeda, Masahiro Tajika, Kazuhide Inaguma, Akio Fujimura, Kei Muro, Kei Irie
Publikováno v:
Cancer Chemotherapy and Pharmacology. 83:107-113
The ability of predicting severe adverse reactions caused by regorafenib is important. We evaluated regorafenib concentrations for adverse reaction risks and assessed the relevance of laboratory values and gene polymorphisms. A total of 28 Japanese c
Autor:
Kanae Mure, Shinichiro Hori, Hiroaki Ikematsu, Toshiyuki Sakai, Tetsuji Takayama, Yoji Takeuchi, Shinji Tanaka, Hideki Ishikawa, Yoshio Ohda, Yasumasa Ezoe, Yasushi Sato, Jun Tashiro, Hisashi Doyama, Takeshi Nakajima, Takahiro Otani, Keiji Wakabayashi, Masahiro Tajika, Takahiro Horimatsu, Sadao Suzuki, Michihiro Mutoh, Hiroshi Kashida
Publikováno v:
The lancet. Gastroenterologyhepatology. 6(6)
The only established treatment for preventing colorectal cancer in patients with familial adenomatous polyposis (FAP) is colectomy, which greatly reduces patient quality of life. Thus, an alternative method is warranted. In this trial, we aimed to cl
Autor:
Masashi Ando, Azusa Komori, Masahiro Tajika, Toshiki Masuishi, Kei Muro, Shigenori Kadowaki, Yukiya Narita, Seiichiro Mitani, Chihiro Kondoh, Kyoko Kato, Tsutomu Tanaka, Kazunori Honda, Hiroya Taniguchi, Isao Oze
Publikováno v:
Advances in therapy. 37(6)
In patients with advanced gastric cancer refractory to chemotherapy, the treatment options are limited. Via this phase II study, we aimed to assess the efficacy and safety of oxaliplatin in combination with 5-fluorouracil and l-leucovorin (modified F
Autor:
Kei Muro, Kyoko Kato, Toshiki Masuishi, Shigenori Kadowaki, Masashi Ando, Seiichiro Mitani, Masahiro Tajika, Hiroya Taniguchi, Takashi Ura, Kazunori Honda, Yukiya Narita
Publikováno v:
Anticancer research. 40(4)
Background/aim The efficacy of treatment using the anti-programmed cell death-1 (anti-PD-1) antibody for metastatic gastric cancer (mGC) has been established previously. Exploratory analyses in various types of tumours suggest that prior exposure to